These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22674083)

  • 21. Meloxicam, a specific COX-2 inhibitor, does not enhance the isoflurane minimum alveolar concentration reduction produced by morphine in the rat.
    Santos M; Kunkar V; García-Iturralde P; Tendillo FJ
    Anesth Analg; 2004 Feb; 98(2):359-363. PubMed ID: 14742370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers.
    Stichtenoth DO; Wagner B; Frölich JC
    J Investig Med; 1997 Feb; 45(2):44-9. PubMed ID: 9084574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.
    Miyazaki I; Asanuma M; Diaz-Corrales FJ; Fukuda M; Kitaichi K; Miyoshi K; Ogawa N
    FASEB J; 2006 Mar; 20(3):571-3. PubMed ID: 16403784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine agonist pergolide prevents levodopa-induced quinoprotein formation in parkinsonian striatum and shows quenching effects on dopamine-semiquinone generated in vitro.
    Miyazaki I; Asanuma M; Diaz-Corrales FJ; Miyoshi K; Ogawa N
    Clin Neuropharmacol; 2005; 28(4):155-60. PubMed ID: 16062092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture.
    Mena MA; Khan U; Togasaki DM; Sulzer D; Epstein CJ; Przedborski S
    J Neurochem; 1997 Jul; 69(1):21-33. PubMed ID: 9202290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
    Datla KP; Blunt SB; Dexter DT
    Mov Disord; 2001 May; 16(3):424-34. PubMed ID: 11391735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of neuroprotective effects of cyclooxygenase inhibitors in the 6-hydroxydopamine induced rat Parkinson model.
    Gören B; Mimbay Z; Bilici N; Zarifoğlu M; Oğul E; Korfali E
    Turk Neurosurg; 2009 Jul; 19(3):230-6. PubMed ID: 19621286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study.
    Villegas I; Martín MJ; La Casa C; Motilva V; De La Lastra CA
    Free Radic Res; 2002 Jul; 36(7):769-77. PubMed ID: 12180128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats.
    Villegas I; Alarcón de la Lastra C; La Casa C; Motilva V; Martín MJ
    Eur J Pharmacol; 2001 Feb; 414(1):79-86. PubMed ID: 11230998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson F; Reilly MP; Kapoor SC; Cucchiara AJ; DeMarco S; Tournier B; Vyas SN; FitzGerald GA
    N Engl J Med; 2001 Dec; 345(25):1809-17. PubMed ID: 11752357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms.
    Mena MA; Casarejos MJ; Carazo A; Paíno CL; García de Yébenes J
    J Neural Transm (Vienna); 1997; 104(4-5):317-28. PubMed ID: 9295168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DopAmide: Novel, Water-Soluble, Slow-Release l-dihydroxyphenylalanine (l-DOPA) Precursor Moderates l-DOPA Conversion to Dopamine and Generates a Sustained Level of Dopamine at Dopaminergic Neurons.
    Atlas D
    CNS Neurosci Ther; 2016 Jun; 22(6):461-7. PubMed ID: 26861609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
    Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
    Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
    Takashima H; Tsujihata M; Kishikawa M; Freed WJ
    Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy with preferential and specific COX-2 inhibitors].
    Stichtenoth DO; Frölich JC
    Internist (Berl); 2001 Mar; 42(3):421-6. PubMed ID: 11277028
    [No Abstract]   [Full Text] [Related]  

  • 36. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Shimizu M; Tanaka K; Ogawa N
    Neurol Res; 2005 Jul; 27(5):533-9. PubMed ID: 15978181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation.
    García J; Carlsson T; Döbrössy M; Nikkhah G; Winkler C
    Exp Neurol; 2011 Dec; 232(2):270-9. PubMed ID: 21946270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2.
    Warner TD; Vojnovic I; Bishop-Bailey D; Mitchell JA
    FASEB J; 2006 Mar; 20(3):542-4. PubMed ID: 16403783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of selective cyclooxygenase (COX)-1 and COX-2 inhibitors on anorexic response and prostaglandin generation in various tissues induced by zymosan.
    Naoi K; Kogure S; Saito M; Hamazaki T; Watanabe S
    Biol Pharm Bull; 2006 Jul; 29(7):1319-24. PubMed ID: 16819161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.